Enhancing Collaboration Management with PharmaCircle's Partnership Tracker: A Strategic Approach to Global Pharma Alliances

Selda Candan

E-Kalite Yazılım

https://orcid.org/0009-0001-9981-5415

DOI: https://doi.org/10.56038/oprd.v5i1.598

Keywords: Global pharma alliances, Product lifecycle, Biotech collaborations, Data analytics, Drug development


Abstract

The pharmaceutical industry involves long and complicated processes for developing new products, changing rules from regulators, and more demands to create new treatments quickly and cheaply. In the last 15 years, the way companies do research, development, marketing, and distribution has changed a lot, with more focus on working together with other companies. These partnerships are important because they help share resources, risks, and speed up the process - which is very important in an industry where developing a product can take over ten years and cost billions of dollars. To help with this, the Partnership Tracker project has created a new platform that makes it easier to analyze these partnerships for both products and companies, helping pharmaceutical companies make better decisions.


References

Sharma, R. (2020). Health Care Collaboration: A Key to Innovation. Journal of Healthcare Management, 65(1), 12-25. DOI: https://doi.org/10.1142/9789813273832_0004

Berger, M. (2021). The Importance of Collaborations in Biotechnology and Pharmaceuticals. Biotechnology Advances, 49, 107745.

Baker, S., et al. (2019). How Artificial Intelligence is Transforming the Pharmaceutical Industry. Harvard Business Review.

PharmaCircle live data